Cynata Therapeutics Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.06 |
Market Cap |
AUD130.41 M |
Shares Outstanding |
101.89 M |
Public Float |
78.3 M |
Address |
62 Lygon Street Carlton Victoria (VIC) 3053 Australia |
Employees | - |
Website | http://www.cynata.com |
Updated | 07/08/2019 |
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on therapeutic stem cell platform technology. The company was founded on March 12, 2003 and is headquartered in Carlton, Australia. |